Orexigen Therapeutics Inc (NASDAQ:OREX)

During the Trading Day
7.55 +0.01 / +0.13%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.36 -0.189 / -2.50%
Volume: 17.6K
Health Technology

Company Description

Orexigen Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of pharmaceutical product candidates for the treatment of obesity. Its product candidate, NB32, is an investigational medicine for weight loss and the maintenance of weight loss; and Empatic used for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded Eckard Weber in September 2002 and is headquartered in La Jolla, CA.

Contact Information

Orexigen Therapeutics, Inc.
3344 North Torrey Pines Court
La Jolla California 92037
P:(858) 875-8600
Investor Relations:
(858) 875-8629



Mutual fund holders43.84%
Other institutional33.76%
Individual stakeholders19.61%

Top Executives

Michael A. NarachiPresident, Chief Executive Officer & Director
Joseph P. HaganCFO, Treasurer & Chief Business Officer
Heather D. TurnerSecretary, Senior Vice President & General Counsel
Preston S. KlassenSenior Vice President & Head-Global Development
Dawn ViveashSenior VP & Head-Global Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account